Lumbar Belt Benefit Compared to the Usual Care in the Treatment of Non-specific Low Back Pain

Last updated: September 4, 2024
Sponsor: Thuasne
Overall Status: Completed

Phase

N/A

Condition

Chronic Pain

Treatment

LombaStab belt

Clinical Study ID

NCT04701073
EC33
2020-003201-54
  • Ages 18-55
  • All Genders

Study Summary

Lumbar belt benefit compared to the usual care in the treatment of non-specific low back pain -an interventional, prospective, multicenter, randomized, open and controlled.study

Eligibility Criteria

Inclusion

Inclusion Criteria:

  • Male or female, aged from 18 to 55 years old

  • Patient suffering from non-specific low back pain with current episode hasprogressed for 1 to 6 months

  • At least one lumbar mean pain at rest or at effort of the last 72 hours collected oninclusion ≥ 40/100 on an NRS scale.

  • Ability of the patient or legally authorized representative to provide a signed anddated i informed consent form before any procedure or data collection.

  • Patient covered by the French Social security system.

Exclusion

Exclusion Criteria:

  • Patient wearing a lumbar belt the day of the inclusion visit

  • Patient who has had surgical intervention on dorso-lumbar spine or lower limb thepast 5 years or who has planned surgery during the study

  • MODIC diagnosis (disc degeneration) known or confirmed by MRI

  • On sick leave for more than 3 consecutive months due to low back pain at the time ofinclusion

  • Low back pain related to an accident at work

  • Low back pain due to secondary origin: tumor, inflammatory, infectious cause,related to a fracture or a vertebral compression

  • Patient with fibromyalgia

  • Patient with lumbar radicular syndrome (radicular conflict like disc herniation,spinal stenosis...)

  • Pregnant woman or trying to become pregnant during the study

  • Patient with confirmed depression

  • Patient with cognitive or mental disorders

  • Morphology with measurements not allowing to match with the sizes of belts available

  • Patient presenting chronic pathology with disabling functional consequences

  • Patient who received an infiltration less than one month before inclusion visit orplanned during the study

  • Patient with known allergy to any of the materials (see product composition in theDescription section of user instruction)

  • Patient with contraindicated to belt wearing: hiatus hernia, deficient respiratoryfunctions

  • Anticipated poor compliance of subject with study procedures

  • Current participation in an interventional investigation drug or device treatmentstudy with an impact on evaluation criteria

Study Design

Total Participants: 168
Treatment Group(s): 1
Primary Treatment: LombaStab belt
Phase:
Study Start date:
February 01, 2021
Estimated Completion Date:
June 20, 2024

Study Description

This is a controlled study, with randomization of the patients, which aims at evaluating the benefit and interest of wearing a new generation lumbar belt, in patients suffering from non-specific low back pain. This trial is also designed to provide quality of life data and to assess the medico-economic interest of wearing such a lumbar belt.

This is an interventional study with low risks and constraints that does not deviate from the local standard of care for enrolled patients. No invasive examination or procedure is performed; as such, there will be no additional risks for participating patients.

203 patients will be followed during 12 weeks in up to 20 investigational sites Patients meeting all eligibility criteria will be included in the study and randomized into one of the two following groups on a 1: 1 ratio.

  • Control group "usual care": promotion of physical activity and taking usual medicines for pain relief

  • Intervention group: wearing the LombaStab belt in addition to usual care (promotion of physical activity and taking usual medicines for pain relief).

Three visits will be performed:

  • Inclusion visit - baseline D0 - V0

  • Follow-up visit at week 4 (+/- 5 days) - V1

  • Follow-up visit at week 12 (+/- 5 days) - V2

At inclusion visit, after verification of the eligibility criteria, data regarding patients will be collected: demographic data, low back pain history, medical and surgical history, concomitant medications.

At each visit will be performed:

  • physical examinations and score assessment by the investigator: ODI score, finger-to-floor distance test, Schober Mac Rae test

  • medical interview with patient in order to collect the following information: description of pain, drug consumption, duration of sick leave and resumption of activity at work, use of medical resources (consultations and complementary).

  • reporting of all AEs and device deficiencies

Patients will be asked to complete on-line questionnaires, following visits and each week.

Connect with a study center

  • CHU Grenoble Alpes

    Grenoble,
    France

    Site Not Available

  • Hôpital Cochin

    Paris,
    France

    Site Not Available

  • CHU de St Etienne

    Saint-Étienne,
    France

    Site Not Available

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.